Buy & Sell Monolithic Power Systems Inc (MPWR) – Monolithic Power Systems Inc Price Today
Aura AI Summary
Key Stats
- $78.58BMarket Cap
- UtilitiesSector
- -18.64%3M Drawdown
- $77.24BEnterprise Value
- 0.5%Dividend Yield
- 51% Buy | 49% SellTrading Activity
- 7 daysTypical Hold Time
Monolithic Power Systems Inc (MPWR) is currently valued at a market capitalization of $78.58B, with an enterprise value of $77.24B. Over the past 52 weeks, Monolithic Power Systems Inc has traded between a low of $661.9 and a high of $1,661.1, highlighting its annual price range. Over the past three months, Monolithic Power Systems Inc has recorded a drawdown of -18.64%, reflecting recent price volatility. Monolithic Power Systems Inc offers a dividend yield of 0.5%. On average, investors hold Monolithic Power Systems Inc for approximately 7 days, indicating typical investor behavior on the platform.
About Monolithic Power Systems Inc
Monolithic Power Systems, Inc. is a global leader in high-performance, analog, and mixed-signal semiconductors. The company specializes in power management solutions, providing integrated circuits (ICs) for a wide range of applications, including computing, automotive, industrial, and communications. MPWR's proprietary process technology is designed to deliver highly energy-efficient and compact power solutions, positioning the company as a key supplier for the next generation of electronic devices.
Most Recent News
Pension officials criticize SpaceX's IPO structure as overly favorable to Elon Musk's control.
Top pension officials from New York and California have expressed concerns about SpaceX's upcoming IPO, criticizing its dual-class share structure that grants Elon Musk significant voting power and control. They warn that this 'most management-favora...
Ipsen presents corabotase, a novel neuro-inhibitor, showing promising phase II results for facial wrinkle treatment.
Ipsen has introduced corabotase, the first molecule in a new class of recombinant neuro-inhibitors, at the SCALE symposium. Phase II trial data show corabotase's safety and efficacy in treating moderate to severe facial wrinkles, including glabellar ...
UK PM Starmer faces leadership challenge as rivals prepare bids, unsettling bond markets.
UK Prime Minister Keir Starmer is facing a potential leadership challenge as Health Secretary Wes Streeting may resign to launch a bid, while Angela Rayner and Andy Burnham are also possible contenders. This political uncertainty has unsettled UK bon...